Fund+ leads EUR38, series B financing in Indigo Diabetes
Fund+, an investment firm focused on European Life Sciences companies, has led a EUR38 million Series B financing in new portfolio company, Indigo Diabetes (Indigo). Indigo is developing a novel ‘invisible’ continuous glucose monitoring device for diabetics. Jan Van den Bossche, Partner at Fund+, will join the Board. Indigo has

